Abstract
Currently, kidney transplantation is the best treatment option for patients with chronic kidney disease in the terminal stage. However, despite the progress achieved with the advent of powerful new immunosuppressive drugs, able to reduce the incidence of graft rejection, the need for their chronic use is associated with significant side effects such as increased risk of opportunistic infe…